D
ClearPoint Neuro, Inc.
CLPT
$13.18
$0.483.78%
D
Sell
8/15/2024Upgraded
ClearPoint Neuro, Inc. (CLPT) was upgraded to D- from E+ on 8/15/2024 due to a noticeable increase in the growth index, solvency index and volatility index. Operating cash flow increased 30.52% from -$3.84M to -$2.67M, total revenue increased 2.87% from $7.64M to $7.86M, and earnings per share increased from -$0.1629 to -$0.1605.
ClearPoint Neuro, Inc. (CLPT) was upgraded to D- from E+ on 8/15/2024 due to a noticeable increase in the growth index, solvency index and volatility index. Operating cash flow increased 30.52% from -$3.84M to -$2.67M, total revenue increased 2.87% from $7.64M to $7.86M, and earnings per share increased from -$0.1629 to -$0.1605.
E
Sell
9/6/2023Downgrade
ClearPoint Neuro, Inc. (CLPT) was downgraded to E+ from D- on 9/6/2023 due to a noticeable decline in the solvency index, total return index and volatility index. Debt to equity increased from 0.32 to 0.38, and the quick ratio declined from 5.68 to 4.72.
ClearPoint Neuro, Inc. (CLPT) was downgraded to E+ from D- on 9/6/2023 due to a noticeable decline in the solvency index, total return index and volatility index. Debt to equity increased from 0.32 to 0.38, and the quick ratio declined from 5.68 to 4.72.
D
Sell
3/14/2023Downgrade
ClearPoint Neuro, Inc. (CLPT) was downgraded to D- from D on 3/14/2023 due to a noticeable decline in the solvency index, growth index and total return index. The quick ratio declined from 7.2 to 5.92, EBIT declined 17.76% from -$3.8M to -$4.47M, and earnings per share declined from -$0.1546 to -$0.1798.
ClearPoint Neuro, Inc. (CLPT) was downgraded to D- from D on 3/14/2023 due to a noticeable decline in the solvency index, growth index and total return index. The quick ratio declined from 7.2 to 5.92, EBIT declined 17.76% from -$3.8M to -$4.47M, and earnings per share declined from -$0.1546 to -$0.1798.
D
Sell
2/23/2023Upgraded
ClearPoint Neuro, Inc. (CLPT) was upgraded to D from D- on 02/23/2023.
ClearPoint Neuro, Inc. (CLPT) was upgraded to D from D- on 02/23/2023.
D
Sell
2/8/2023Downgrade
ClearPoint Neuro, Inc. (CLPT) was downgraded to D- from D on 2/8/2023 due to a decline in the total return index and valuation index.
ClearPoint Neuro, Inc. (CLPT) was downgraded to D- from D on 2/8/2023 due to a decline in the total return index and valuation index.
D
Sell
5/31/2022Upgraded
ClearPoint Neuro, Inc. (CLPT) was upgraded to D from D- on 5/31/2022 due to an increase in the total return index and volatility index.
ClearPoint Neuro, Inc. (CLPT) was upgraded to D from D- on 5/31/2022 due to an increase in the total return index and volatility index.
D
Sell
5/13/2022Downgrade
ClearPoint Neuro, Inc. (CLPT) was downgraded to D- from D on 5/13/2022 due to a decline in the solvency index. Debt to equity increased from 0.21 to 0.23.
ClearPoint Neuro, Inc. (CLPT) was downgraded to D- from D on 5/13/2022 due to a decline in the solvency index. Debt to equity increased from 0.21 to 0.23.
D
Sell
5/4/2022Upgraded
ClearPoint Neuro, Inc. (CLPT) was upgraded to D from D- on 5/4/2022 due to an increase in the valuation index and solvency index. Debt to equity declined from 0.41 to 0.21.
ClearPoint Neuro, Inc. (CLPT) was upgraded to D from D- on 5/4/2022 due to an increase in the valuation index and solvency index. Debt to equity declined from 0.41 to 0.21.
D
Sell
4/20/2022Downgrade
ClearPoint Neuro, Inc. (CLPT) was downgraded to D- from D on 4/20/2022 due to a decline in the total return index and volatility index.
ClearPoint Neuro, Inc. (CLPT) was downgraded to D- from D on 4/20/2022 due to a decline in the total return index and volatility index.
D
Sell
11/15/2021Upgraded
ClearPoint Neuro, Inc. (CLPT) was upgraded to D from D- on 11/15/2021 due to an increase in the valuation index.
ClearPoint Neuro, Inc. (CLPT) was upgraded to D from D- on 11/15/2021 due to an increase in the valuation index.
D
Sell
11/8/2021Downgrade
ClearPoint Neuro, Inc. (CLPT) was downgraded to D- from D on 11/8/2021 due to a major decline in the growth index and valuation index. Operating cash flow declined 74.47% from -$2.13M to -$3.72M, EBIT declined 56.21% from -$2.18M to -$3.41M, and earnings per share declined from -$0.1346 to -$0.1739.
ClearPoint Neuro, Inc. (CLPT) was downgraded to D- from D on 11/8/2021 due to a major decline in the growth index and valuation index. Operating cash flow declined 74.47% from -$2.13M to -$3.72M, EBIT declined 56.21% from -$2.18M to -$3.41M, and earnings per share declined from -$0.1346 to -$0.1739.
D
Sell
5/1/2020Upgraded
ClearPoint Neuro, Inc. (CLPT) was upgraded to D from D- on 5/1/2020 due to a substantial increase in the total return index, volatility index and growth index. Operating cash flow increased 51.69% from -$964.1 to -$465.8, and total revenue increased 9.67% from $2.93M to $3.21M.
ClearPoint Neuro, Inc. (CLPT) was upgraded to D from D- on 5/1/2020 due to a substantial increase in the total return index, volatility index and growth index. Operating cash flow increased 51.69% from -$964.1 to -$465.8, and total revenue increased 9.67% from $2.93M to $3.21M.
D
Sell
11/19/2018Upgraded
MRI Interventions, Inc. (MRIC) was upgraded to D- from E+ on 11/19/2018 due to an increase in the volatility index.
MRI Interventions, Inc. (MRIC) was upgraded to D- from E+ on 11/19/2018 due to an increase in the volatility index.
E
Sell
9/28/2018Downgrade
MRI Interventions, Inc. (MRIC) was downgraded to E+ from D- on 9/28/2018 due to a decline in the solvency index, total return index and efficiency index. Debt to equity increased from 1.06 to 1.46, the quick ratio declined from 1.49 to 1.26, and net income declined 14.36% from -$1.64M to -$1.88M.
MRI Interventions, Inc. (MRIC) was downgraded to E+ from D- on 9/28/2018 due to a decline in the solvency index, total return index and efficiency index. Debt to equity increased from 1.06 to 1.46, the quick ratio declined from 1.49 to 1.26, and net income declined 14.36% from -$1.64M to -$1.88M.
D
Sell
3/23/2018Downgrade
MRI Interventions, Inc. (MRIC) was downgraded to D- from D on 3/23/2018 due to a decline in the efficiency index, valuation index and growth index. Net income declined 46.03% from -$1.43M to -$2.08M, earnings per share declined from -$0.1379 to -$0.1969, and EBIT declined 38.07% from -$1.33M to -$1.83M.
MRI Interventions, Inc. (MRIC) was downgraded to D- from D on 3/23/2018 due to a decline in the efficiency index, valuation index and growth index. Net income declined 46.03% from -$1.43M to -$2.08M, earnings per share declined from -$0.1379 to -$0.1969, and EBIT declined 38.07% from -$1.33M to -$1.83M.
D
Sell
8/15/2017Upgraded
MRI Interventions, Inc. (MRIC) was upgraded to D from D- on 8/15/2017 due to a substantial increase in the solvency index, valuation index and volatility index. The quick ratio increased from 0.92 to 4.6.
MRI Interventions, Inc. (MRIC) was upgraded to D from D- on 8/15/2017 due to a substantial increase in the solvency index, valuation index and volatility index. The quick ratio increased from 0.92 to 4.6.
D
Sell
12/5/2016Downgrade
MRI Interventions, Inc. (MRIC) was downgraded to D- from D on 12/5/2016 due to a decline in the volatility index and total return index.
MRI Interventions, Inc. (MRIC) was downgraded to D- from D on 12/5/2016 due to a decline in the volatility index and total return index.
D
Sell
11/18/2016Upgraded
MRI Interventions, Inc. (MRIC) was upgraded to D from E+ on 11/18/2016 due to a noticeable increase in the growth index and efficiency index. Total capital increased 137.83% from $2.09M to $4.96M, total revenue increased 46.42% from $1.1M to $1.62M, and EBIT increased 16.82% from -$2.06M to -$1.71M.
MRI Interventions, Inc. (MRIC) was upgraded to D from E+ on 11/18/2016 due to a noticeable increase in the growth index and efficiency index. Total capital increased 137.83% from $2.09M to $4.96M, total revenue increased 46.42% from $1.1M to $1.62M, and EBIT increased 16.82% from -$2.06M to -$1.71M.
E
Sell
8/18/2016Downgrade
MRI Interventions, Inc. (MRICD) was downgraded to E+ from D- on 8/18/2016 due to a decline in the efficiency index, solvency index and volatility index. Total capital declined 53.45% from $4.48M to $2.09M, the quick ratio declined from 1.57 to 0.77, and debt to equity increased from -2.24 to -1.53.
MRI Interventions, Inc. (MRICD) was downgraded to E+ from D- on 8/18/2016 due to a decline in the efficiency index, solvency index and volatility index. Total capital declined 53.45% from $4.48M to $2.09M, the quick ratio declined from 1.57 to 0.77, and debt to equity increased from -2.24 to -1.53.
D
Sell
3/11/2016Downgrade
MRI Interventions, Inc. (MRIC) was downgraded to D- from D+ on 3/11/2016 due to a substantial decline in the volatility index and total return index.
MRI Interventions, Inc. (MRIC) was downgraded to D- from D+ on 3/11/2016 due to a substantial decline in the volatility index and total return index.
D
Sell
11/20/2015Upgraded
MRI Interventions, Inc. (MRIC) was upgraded to D+ from D on 11/20/2015 due to a noticeable increase in the efficiency index and valuation index. Total capital increased 8.22% from $2.01M to $2.17M.
MRI Interventions, Inc. (MRIC) was upgraded to D+ from D on 11/20/2015 due to a noticeable increase in the efficiency index and valuation index. Total capital increased 8.22% from $2.01M to $2.17M.
D
Sell
3/20/2015Downgrade
MRI Interventions, Inc. (MRIC) was downgraded to D from C- on 3/20/2015 due to a significant decline in the efficiency index, total return index and volatility index. Total capital declined 2,459.43% from -$321.7 to $7.59M, and net income declined 47.5% from -$3.65M to -$1.91M.
MRI Interventions, Inc. (MRIC) was downgraded to D from C- on 3/20/2015 due to a significant decline in the efficiency index, total return index and volatility index. Total capital declined 2,459.43% from -$321.7 to $7.59M, and net income declined 47.5% from -$3.65M to -$1.91M.
C
Hold
11/26/2014Upgraded
MRI Interventions, Inc. (MRIC) was upgraded to C- from D on 11/26/2014 due to a significant increase in the efficiency index, volatility index and total return index. Net income increased 128.94% from -$1.59M to -$3.65M.
MRI Interventions, Inc. (MRIC) was upgraded to C- from D on 11/26/2014 due to a significant increase in the efficiency index, volatility index and total return index. Net income increased 128.94% from -$1.59M to -$3.65M.
D
Sell
5/27/2014Downgrade
MRI Interventions, Inc. (MRIC) was downgraded to D from D+ on 5/27/2014 due to a significant decline in the volatility index, growth index and efficiency index. Net income declined 253.3% from -$1.72M to $2.63M, earnings per share declined from -$0.03 to $0.04, and total revenue declined 30.08% from $1.18M to $822.5.
MRI Interventions, Inc. (MRIC) was downgraded to D from D+ on 5/27/2014 due to a significant decline in the volatility index, growth index and efficiency index. Net income declined 253.3% from -$1.72M to $2.63M, earnings per share declined from -$0.03 to $0.04, and total revenue declined 30.08% from $1.18M to $822.5.
NASDAQ
03/12/2025 4:00PM Eastern
Quotes delayed
